Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
This study will investigate the types of HPV in samples from women with cervical pre-cancer
 and cancer and gather information to help investigate the impact of HPV vaccination in
 Switzerland.
Inclusion Criteria:

 -  Participant is willing and able to give informed consent for participation in the
 study.

 -  Participant is literate in German, French, Italian or English.

 -  Female, aged 18 years or above.

 -  Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive
 carcinoma of the cervix.

 -  Participant resides in the canton Zurich, Geneva, Basel, Baselland, Luzern or Ticino.

 Exclusion Criteria:

 -  None